1. Home
  2. ETNB vs RDWR Comparison

ETNB vs RDWR Comparison

Compare ETNB & RDWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • RDWR
  • Stock Information
  • Founded
  • ETNB 2018
  • RDWR 1996
  • Country
  • ETNB United States
  • RDWR Israel
  • Employees
  • ETNB N/A
  • RDWR N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • RDWR EDP Services
  • Sector
  • ETNB Health Care
  • RDWR Technology
  • Exchange
  • ETNB Nasdaq
  • RDWR Nasdaq
  • Market Cap
  • ETNB 1.0B
  • RDWR 889.9M
  • IPO Year
  • ETNB 2019
  • RDWR 1999
  • Fundamental
  • Price
  • ETNB $10.05
  • RDWR $23.74
  • Analyst Decision
  • ETNB Strong Buy
  • RDWR Hold
  • Analyst Count
  • ETNB 8
  • RDWR 4
  • Target Price
  • ETNB $26.43
  • RDWR $27.00
  • AVG Volume (30 Days)
  • ETNB 2.1M
  • RDWR 172.0K
  • Earning Date
  • ETNB 05-01-2025
  • RDWR 05-07-2025
  • Dividend Yield
  • ETNB N/A
  • RDWR N/A
  • EPS Growth
  • ETNB N/A
  • RDWR N/A
  • EPS
  • ETNB N/A
  • RDWR 0.27
  • Revenue
  • ETNB N/A
  • RDWR $281,874,000.00
  • Revenue This Year
  • ETNB N/A
  • RDWR $10.38
  • Revenue Next Year
  • ETNB N/A
  • RDWR $7.14
  • P/E Ratio
  • ETNB N/A
  • RDWR $87.33
  • Revenue Growth
  • ETNB N/A
  • RDWR 9.54
  • 52 Week Low
  • ETNB $4.16
  • RDWR $17.01
  • 52 Week High
  • ETNB $11.84
  • RDWR $25.00
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 68.44
  • RDWR 54.24
  • Support Level
  • ETNB $8.94
  • RDWR $22.92
  • Resistance Level
  • ETNB $9.70
  • RDWR $23.97
  • Average True Range (ATR)
  • ETNB 0.73
  • RDWR 0.46
  • MACD
  • ETNB 0.14
  • RDWR -0.07
  • Stochastic Oscillator
  • ETNB 93.78
  • RDWR 39.51

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.

Share on Social Networks: